H Nida Sen Selected Research

Scleritis (Episcleritis)

1/2022	Corneal Endothelial Transplantation in Uveitis: Incidence and Risk Factors.
1/2021	Remission of Non-Infectious Anterior Scleritis: Incidence and Predictive Factors.
12/2016	Gevokizumab in the Treatment of Autoimmune Non-necrotizing Anterior Scleritis: Results of a Phase I/II Clinical Trial.
3/2015	Subconjunctival sirolimus in the treatment of autoimmune non-necrotizing anterior scleritis: results of a phase I/II clinical trial.
8/2012	Interleukin-2 receptor targeted therapy of ocular disease of HTLV-1-associated adult T-cell leukemia.
6/2009	Infliximab for the treatment of active scleritis.
9/2003	Mycophenolate mofetil for the treatment of scleritis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

H Nida Sen Research Topics

Disease

36	Uveitis 07/2022 - 11/2004
19	Inflammation (Inflammations) 01/2022 - 09/2003
7	Scleritis (Episcleritis) 01/2022 - 09/2003
6	Cataract (Cataracts) 01/2022 - 12/2004
6	Lymphoma (Lymphomas) 01/2020 - 01/2008
5	Anterior Uveitis 01/2022 - 11/2009
5	Panuveitis 12/2017 - 06/2010
5	Macular Degeneration (Age-Related Maculopathy) 01/2017 - 11/2010
5	Autoimmune Diseases (Autoimmune Disease) 06/2015 - 11/2004
4	Neoplasms (Cancer) 01/2021 - 11/2004
4	Sarcoidosis (Schaumann Disease) 12/2017 - 06/2013
4	Choroidal Neovascularization 01/2017 - 11/2010
3	Posterior Uveitis 01/2022 - 06/2016
3	Intermediate Uveitis (Chronic Cyclitis) 12/2021 - 11/2014
3	Intraocular Lymphoma 01/2020 - 01/2008
3	Infections 01/2019 - 09/2012
3	Blindness (Hysterical Blindness) 01/2019 - 08/2009
3	Hypertension (High Blood Pressure) 06/2018 - 03/2016
3	Retinal Detachment (Retinal Detachments) 01/2018 - 06/2010
2	Uveomeningoencephalitic Syndrome (Vogt Koyanagi Harada Syndrome) 07/2022 - 11/2019
2	Granuloma 12/2020 - 12/2017
2	White Dot Syndromes 12/2020 - 06/2016
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2019 - 11/2009
2	Photophobia (Light Sensitivity) 06/2018 - 03/2004
2	Retinitis 05/2018 - 12/2005
2	Birdshot Chorioretinopathy 04/2017 - 11/2016
2	Disease Progression 07/2014 - 11/2010
2	Ocular Paraneoplastic Syndromes 02/2014 - 12/2013
2	Melanoma (Melanoma, Malignant) 12/2013 - 11/2004
2	Macular Edema 09/2012 - 09/2011
2	Exanthema (Rash) 11/2009 - 06/2009
1	Band-Shaped Corneal Dystrophy 01/2022
1	Glaucoma 01/2022
1	Ocular Hypertension (Glaucoma, Suspect) 01/2022
1	Retinal Diseases 06/2021
1	Atrophy 04/2021
1	Ocular Tuberculosis 12/2020
1	WHIM syndrome 01/2019
1	Primary Immunodeficiency Diseases 01/2019

Drug/Important Bio-Agent (IBA)

14	Retinaldehyde (Retinal)IBA 02/2022 - 08/2011
14	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 09/2012
7	Biomarkers (Surrogate Marker)IBA 06/2021 - 01/2011
7	Interleukin-17 (Interleukin 17)IBA 07/2014 - 10/2008
5	Prednisone (Sone)FDA LinkGeneric 01/2021 - 09/2003
5	SteroidsIBA 06/2018 - 09/2003
5	Immunosuppressive Agents (Immunosuppressants)IBA 06/2018 - 09/2003
4	Infliximab (Remicade)FDA Link 01/2021 - 06/2009
4	Monoclonal AntibodiesIBA 01/2019 - 11/2004
4	Methotrexate (Mexate)FDA LinkGeneric 01/2019 - 09/2003
4	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2004
4	Fluorescein (Funduscein)FDA LinkGeneric 06/2016 - 09/2012
3	Immune Checkpoint InhibitorsIBA 01/2021 - 01/2020
3	Biological ProductsIBA 01/2019 - 07/2013
3	GlucocorticoidsIBA 01/2019 - 06/2015
3	AntibodiesIBA 12/2014 - 03/2004
3	Rituximab (Mabthera)FDA Link 01/2014 - 06/2010
3	AutoantibodiesIBA 12/2013 - 04/2013
2	Pharmaceutical PreparationsIBA 01/2020 - 06/2012
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 10/2008
2	CytokinesIBA 01/2020 - 12/2013
2	InterleukinsIBA 01/2020 - 12/2016
2	Adalimumab (Humira)FDA Link 01/2019 - 01/2019
2	Tumor Necrosis Factor InhibitorsIBA 01/2019 - 01/2019
2	Retinal Pigments (Pigments, Visual)IBA 12/2017 - 10/2008
2	Fluocinolone Acetonide (Capex)FDA LinkGeneric 01/2017 - 01/2016
2	Indocyanine Green (Cardio-Green)FDA LinkGeneric 06/2016 - 12/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 11/2010
2	Sirolimus (Rapamycin)FDA Link 03/2015 - 06/2012
2	Complement Factor H (Factor H)IBA 07/2014 - 06/2013
2	AntimetabolitesIBA 07/2013 - 09/2003
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 08/2012 - 01/2011
2	Ganciclovir (Cytovene)FDA LinkGeneric 01/2012 - 12/2005
2	AntigensIBA 08/2011 - 11/2004
2	Interleukin-22 (IL-22)IBA 07/2011 - 10/2008
1	difluprednate FDA Link 01/2022
1	Phenobarbital (Luminal)FDA Link 12/2021
1	GoldIBA 10/2021
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021
1	Biosimilar PharmaceuticalsIBA 01/2021
1	avelumabIBA 01/2020
1	lipoxin A4IBA 01/2020
1	NivolumabIBA 01/2020
1	IpilimumabIBA 01/2020
1	pembrolizumabIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	atezolizumabIBA 01/2020
1	durvalumabIBA 01/2020
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 11/2019
1	Sulfamethoxazole Drug Combination Trimethoprim (Co-Trimoxazole)FDA LinkGeneric 01/2019
1	chlorotriphenylsilane (CTPS)IBA 01/2019

Therapy/Procedure

22	Therapeutics 01/2022 - 11/2004
5	Vitrectomy 01/2017 - 05/2010
4	Injections 01/2021 - 12/2005
2	Lasers (Laser) 11/2016 - 09/2013
2	Intravitreal Injections 01/2016 - 01/2014
2	Drug Therapy (Chemotherapy) 02/2014 - 01/2014
1	Tattooing 07/2022
1	Transplantation 01/2022
1	Trabeculectomy (Trabeculoplasty) 01/2022